The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

2018

Stage

Series A - III | Alive

Total Raised

$59.08M

Last Raised

$35M | 1 yr ago

About Lupeng Pharma

Lupeng Pharma specializes in small-molecule drug development for cancers, hepatitis B, and other diseases.

Lupeng Pharma Headquarter Location

Guangzhou, Guangdong,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Lupeng Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lupeng Pharma is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Lupeng Pharma News

Lupeng Pharma Closes $35 Million Pre-B Funding for Novel Drugs

Jul 30, 2021

publication date: Jul 30, 2021 Guangzhou Lupeng Pharmaceutical completed a $35 million pre-B financing led by Temasek. The company will use the funds for global clinical development of its lead drug, a selective Bcl-2 inhibitor, along with advancing at least four other candidates into clinical trials. Founded in 2018, Lupeng aims to develop global best-in-class therapies. The company develops novel small molecule drugs for cancer, hepatitis B and autoimmune diseases. Lupeng is approved to conduct clinical trials of its lead Bcl-2 inhibitor in China

  • When was Lupeng Pharma founded?

    Lupeng Pharma was founded in 2018.

  • Where is Lupeng Pharma's headquarters?

    Lupeng Pharma's headquarters is located at Guangzhou.

  • What is Lupeng Pharma's latest funding round?

    Lupeng Pharma's latest funding round is Series A - III.

  • How much did Lupeng Pharma raise?

    Lupeng Pharma raised a total of $59.08M.

  • Who are the investors of Lupeng Pharma?

    Investors of Lupeng Pharma include Lilly Asia Ventures, FC Capital, Temasek, Lake Bleu Capital, Kaitai Capital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.